Gri Bio Inc (GRI)

02:58 AM

Is GRI Bio Inc. a good long term investmentFree Trend-Following Techniques - Autocar Professional

02:58 AM

12:23 PM

What analysts say about GRI Bio Inc. stockConsistent high-performance stocks - jammulinksnews.com

12:23 PM

Jul 22, 2025

GRI Bio Inc. Stock Analysis and ForecastSuperior trading gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives GRI Bio Inc. stock priceOver 200% growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

GRI Bio Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times

Jul 22, 2025

Jul 22, 2025

GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference - GlobeNewswire

Jul 22, 2025

Jul 22, 2025

GRI Bio CEO Unveils Strategic Vision for Revolutionary NKT Cell Platform in Exclusive Interview - Stock Titan

Jul 22, 2025

Jul 20, 2025

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - The Globe and Mail

Jul 20, 2025

Jul 18, 2025

JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Knoxville News Sentinel

Jul 18, 2025

Jul 17, 2025

AI in Retail and Consumer Goods5x Profit Potential - Newser

Jul 17, 2025

Jul 16, 2025

COLX(colossuscoinxt) Price TodayFast Growing Stocks - Newser

Jul 16, 2025

Jul 15, 2025

What makes GRI Bio Inc. stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025

Jul 15, 2025

How GRI Bio Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser

Jul 15, 2025

Jul 15, 2025

Why Eli Lilly and Company stock attracts strong analyst attentionSmart Money Signals - Newser

Jul 15, 2025

Jul 15, 2025

Why GRI Bio Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser

Jul 15, 2025

Jul 02, 2025

GRI Bio stock holds Buy rating at H.C. Wainwright as Phase 2a trial completes enrollment - Investing.com

Jul 02, 2025

Jul 01, 2025

GRI Bio, Inc. Completes Patient Enrollment in Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis, Interim Results Show Safety and Tolerability - Nasdaq

Jul 01, 2025

Jun 30, 2025

GRI Bio's GRI-0621: A Breakthrough in IPF with Near-Term Catalysts and a Growing Market - AInvest

Jun 30, 2025

Jun 27, 2025

GRI Bio approves reverse stock split, stockholders vote in favor - MSN

Jun 27, 2025

Jun 26, 2025

GRI Bio, Inc. Reports Positive 6-Week Interim Safety Results from its Ongoing Phase 2a Study Evaluating GRI-0621 for Treatment of Idiopathic Pulmonary Fibrosis - MarketScreener

Jun 26, 2025

Jun 14, 2025

Q2 Earnings Estimate for GRI Bio Issued By HC Wainwright - Defense World

Jun 14, 2025

Jun 12, 2025

Kalkine : GRI Bio Advancing in the Nasdaq Composite Healthcare Space - Kalkine Media

Jun 12, 2025

Jun 12, 2025

GRI Bio (NASDAQ:GRI) Receives “Buy” Rating from HC Wainwright - Defense World

Jun 12, 2025

Jun 12, 2025

HC Wainwright Reiterates Buy Rating for GRI Bio (NASDAQ:GRI) - Defense World

Jun 12, 2025

Jun 12, 2025

GRI Bio’s (GRI) Buy Rating Reiterated at HC Wainwright - Defense World

Jun 12, 2025

Jun 12, 2025

GRI Bio (NASDAQ:GRI) Given “Buy” Rating at HC Wainwright - Defense World

Jun 12, 2025

Jun 12, 2025

GRI Bio (NASDAQ:GRI) Earns Buy Rating from HC Wainwright - Defense World

Jun 12, 2025

Jun 12, 2025

GRI Bio’s (GRI) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Jun 12, 2025